Jamie Christensen, EVP & Chief Scientific Officer at Mirati Therapeutics, Inc. (MRTX), sold 3,062 shares at $58.81 ($180K) on 2024-01-04, disclosed to the SEC on 2024-01-05.
Seasonal sale ($180k) by EVP & Chief Scientific Officer — this insider has traded MRTX in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.81 | 1,531 | $90K | 50.0% |
| 2 | $58.81 | 1,531 | $90K | 50.0% |
| Total | $58.81 avg | 3,062 | $180K | 100% |
| Filing → |
| MRTX | SELL | 2023-09-12 | $170K | — | Filing → |
| MRTX | SELL | 2023-05-24 | $28K | — | Filing → |
| MRTX | SELL | 2023-01-19 | $153K | — | Filing → |